TrialBMC medical genomics2020

Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.

Jacqueline S Dron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.